Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound drug for arthromeningitis and method for preparing compound drug for arthromeningitis

A production method and technology for formulating medicines, which are applied in pharmaceutical formulas, medical preparations containing active ingredients, and drug combinations, etc., can solve problems such as stomach damage, and achieve the effects of less side effects, relieve muscle tension, and strong blood-activating power.

Active Publication Date: 2013-01-30
王旭时
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In the prior art, there is a traditional Chinese medicine formula for treating proliferative synovitis of the knee joint, which is prepared from the following Chinese medicinal materials by weight: Gentiana xiqin 10-15 parts, Atractylodes rhizome 10-15 parts, Atractylodes rhizome 10-15 parts , 25-35 parts of honeysuckle, 20-30 parts of Fuling bark, 25-35 parts of coix seed, 10-20 parts of Dipsacus chuanxiong, 15-25 parts of Sichuan achyranthes bidentata, etc., and most of the Chinese herbal medicines are hard-working , such as Gentiana xiqin and Atractylodes atractylodes are pungent and bitter, and the hard medicine has a stimulating effect on the stomach, and it will hurt the stomach if taken for a long time, and synovitis is a chronic disease that requires long-term treatment, so taking this prescription for a long time to treat synovitis will have negative stomach damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound drug for arthromeningitis and method for preparing compound drug for arthromeningitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments It is a part of embodiments of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0028] The embodiment of the present invention provides a prescription drug for synovitis, which is prepared from the following raw materials:

[0029] 3-5 parts of rehmannia glutinosa, 1-3 parts of kudzu root, 3-5 parts of astragalus, 3-4 parts of elm yellow mushroom, 2-3 parts of Panax notoginseng and 3-4 parts of cornus.

[0030] The rati...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a compound drug for arthromeningitis. The compound drug is prepared from the following active pharmaceutical ingredients in parts by weight: 3-5 parts of rehmannia glutinosa, 1-3 parts of radix puerariae, 3-5 parts of radix astragali, 3-4 parts of pleurotus citrinopileatus, 2-3 parts of radix notoginseng and 3-4 parts of fructus corni. The invention further discloses a method for preparing the compound drug for arthromeningitis. The method comprises the steps that: step A, in parts by weight, 3-4 parts of the pleurotus citrinopileatus, 3-5 parts of rehmannia glutinosa and 3-5 parts of radix astragali are cleaned and then soaked in water, are fished out and then added with water to be decocted, the dregs of decoction are filtered, and the decoction is concentrated to be thick; step B, 3-4 parts of the fructus corni, 1-3 parts of the radix puerariae and 2-3 parts of the radix notoginseng are ground into powder so as to be mixed with the thick decoction which is obtain in the step A, and the mixture is dried; and step C, the dried mixture is put in a grinder to be ground and is produced to form various drug forms. According to the compound drug for arthromeningitis and the method for preparing the compound drug for arthromeningitis, the arthromeningitis is treated and the stomach is also protected.

Description

technical field [0001] The invention relates to the technical field of medicine and health care products, in particular to a formula medicine for synovitis and a preparation method thereof. Background technique [0002] Synovitis (English name synovitis) is a degenerative change of bone, and its diseased site is mainly in the knee joint, and patients are mostly middle-aged and elderly people. The knee joint is the joint with the most synovium, the largest articular surface and the most complex structure in the human body. Because the knee joint synovium is extensive and located in the shallower part of the limb surface, there are more chances of injury and infection. Knee synovitis is mainly caused by A group of syndromes caused by knee sprains and various intra-articular injuries. Synovitis is likely to cause temporary or long-term partial loss of labor in patients, which is more harmful to patients and society. Although there are many effective treatments, there are stil...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/804A61P19/04
Inventor 王旭时
Owner 王旭时
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products